Safety & Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

See also
Status	Clinical Trial	Phase
Completed	`NCT00370253` - Noradrenalin vs Terlipressin in Hepatorenal Syndrome	Phase 3
Completed	`NCT00359853` - Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis	Phase 4
Completed	`NCT01143246` - A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin	Phase 3
Recruiting	`NCT05346393` - HRS-AKI Treatment With TIPS in Patients With Cirrhosis	N/A
Terminated	`NCT00734136` - Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome	N/A
Terminated	`NCT00742339` - Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome	Phase 2/Phase 3
Recruiting	`NCT06095440` - A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center
Completed	`NCT02097784` - Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury	N/A
Recruiting	`NCT04898010` - The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I	N/A
Recruiting	`NCT05875948` - Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome	Phase 2
Completed	`NCT04416282` - Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.	N/A
Recruiting	`NCT02049125` - Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis	N/A
Completed	`NCT00764049` - Single Pass Albumin Dialysis in Patients With Cirrhosis	Phase 1/Phase 2
Completed	`NCT00089570` - Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1	Phase 3
Withdrawn	`NCT01587222` - Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure	Phase 2
Recruiting	`NCT02489864` - The Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial Pressure	Phase 4
Recruiting	`NCT02434445` - Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients	N/A
Completed	`NCT02770716` - Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1	Phase 3
Completed	`NCT05387811` - International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
Withdrawn	`NCT04048707` - Angiotensin 2 for Hepatorenal Syndrome	Phase 2

NCT number	NCT01436500
Study type	Interventional
Source	Cumberland Pharmaceuticals
Contact
Status	Completed
Phase	Phase 2
Start date	October 2011
Completion date	July 2015

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms